PMGC HOLDINGS INC. Derivative Liability, Current
PMGC HOLDINGS INC. (ELAB) had Derivative Liability, Current of $743.94 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Derivative Liability, Current $743.94K.
- 2026-03-31: Derivative Liability, Current $2.51M.
- 2025-12-31: Derivative Liability, Current $418.41K.
- 2025-09-30: Derivative Liability, Current $681.82K.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $743.94K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.51M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $418.41K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $681.82K 10-Q · filed 2025-11-14 | |
| 2024-09-30 | $1.88K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $67.36K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $94.22K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $369.16K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $519.51M 10-Q · filed 2023-12-11 | |
| 2022-12-31 | $68.45K 10-K · filed 2024-03-29 | $68.45M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |